Drugs that contain Emtricitabine; Rilpivirine Hydrochloride; Tenofovir Disoproxil Fumarate

1. Drug name - COMPLERA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8080551 GILEAD SCIENCES INC HIV inhibiting pyrimidines derivatives
Apr, 2023

(6 months from now)

US7125879 GILEAD SCIENCES INC HIV inhibiting pyrimidines derivatives
Apr, 2025

(2 years from now)

CN101056673A GILEAD SCIENCES INC 4-[[4-[[4-(2-Cyanovinyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidyl]Amino] Benzonitrile Hydrochloride
Jun, 2015

(7 years ago)

CN101816658A GILEAD SCIENCES INC Pyramine Derivatives For Inhibiting Hiv
Aug, 2022

(a month ago)

CN101816658B GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

CN1541215A GILEAD SCIENCES INC Hiv Inhibiting Pyrimidine Derivatives
Aug, 2022

(a month ago)

CN100509801C GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

CN101060844A GILEAD SCIENCES INC Composition Of Rt Inhibitor And Nnrti Containing Pyrimidine
Sep, 2024

(1 year, 10 months from now)

CN101068597A GILEAD SCIENCES INC Fumaric Acid Salt Of 4-((4-((4-(2-Cyanovinyl)-2, 6-) Dimethylphenyl Amido)-2- Pyrimidyl) Amido) Benzonitrile
Sep, 2024

(1 year, 10 months from now)

CN101068597B GILEAD SCIENCES INC 4 - ((4 - ((4 - (2) -2, 6 -) Dimethylphenyl Amido) -2 - Pyrimidyl) Amido) Benzonitrile
Sep, 2024

(1 year, 10 months from now)

CN101060844B GILEAD SCIENCES INC Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Sep, 2024

(1 year, 10 months from now)

IN200400265P1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

IN222987B GILEAD SCIENCES INC A Pyrimidine Compound Of Formula (I)
Aug, 2022

(a month ago)

EP1663240A1 GILEAD SCIENCES INC Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Jul, 2020

(2 years ago)

EP1663240B1 GILEAD SCIENCES INC Combinations Of A Pyrimidine Containing Nnrti With Rt Inhibitors
Jul, 2020

(2 years ago)

EP1632232A1 GILEAD SCIENCES INC Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile
Feb, 2022

(7 months ago)

EP1632232B1 GILEAD SCIENCES INC Salt Of 4[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]Amino]-2-Pyrimidinyl]Amino]Benzonitrile
Feb, 2022

(7 months ago)

EP3808743B1 GILEAD SCIENCES INC Hiv Replication Inhibiting Pyrimidines
Aug, 2022

(a month ago)

EP2298761B1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

EP3808743A1 GILEAD SCIENCES INC Hiv Replication Inhibiting Pyrimidines
Aug, 2022

(a month ago)

EP2298761A1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Aug, 2022

(a month ago)

EP1789139A1 GILEAD SCIENCES INC Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile
Sep, 2025

(2 years from now)

EP1789139B1 GILEAD SCIENCES INC Fumarate Of 4-((4-((4-(2-Cyanoethenyl)-2,6-Dimethylphenyl Amino -2-Pyrimidinyl Amino Benzonitrile
Sep, 2025

(2 years from now)

EP1419152B1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Nov, 2026

(4 years from now)

EP1419152A1 GILEAD SCIENCES INC Hiv Inhibiting Pyrimidines Derivatives
Nov, 2026

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9744181 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US8592397 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US9457036 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US8716264 GILEAD SCIENCES INC Compositions and methods for combination antiviral therapy Jan, 2024

(1 year, 3 months from now)

US8841310 GILEAD SCIENCES INC Combinations of a pyrimidine containing NNRTI with RT inhibitors Dec, 2025

(3 years from now)

US10857102 GILEAD SCIENCES INC Therapeutic compositions comprising rilpivirine HCL and tenofovir disoproxil fumarate Jan, 2033

(10 years from now)

Treatment: Treatment of hiv infection

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
200MG;EQ 25MG BASE;300MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.